Arrow keys move between marks; Enter selects; F opens full screen.

Skip to content
Procura
Get started

Revivocell Inc.

Correct this listing

UEIUEI: the 12-character ID the government gives every company registered for federal work. It replaced the DUNS number in April 2022. Glossary R7EYRQWWQHU5· CAGECAGE code: a 5-character code that identifies one company location for federal work. A company with several sites can have several. Glossary 9YW63· BRONX, NY· Active registration until Sep 25, 2027· revivocell.com (opens in a new tab)

Overview

Registered industries (NAICS)

Registered in 5 industries; primary 541714

  • 325414 Biological Product (except Diagnostic) Manufacturing
  • 334516 Analytical Laboratory Instrument Manufacturing
  • 541690 Other Scientific and Technical Consulting Services
  • 541714 Research and Development in Biotechnology (except Nanobiotechnology)
  • 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

No prime contract or subcontract to this company appears in the federal contract records from FY2001 on.

About

From the company's SBA profile, updated Oct 2025

Revivocell Inc. develops next-generation human-relevant microphysiological systems (MPS) for drug discovery, safety, and efficacy testing. Using its patented NANOSTACKS™ and CELLBLOKS® platforms, Revivocell recreates complex multicellular human organ and multi-organ models that incorporate physiological flow, immune competence, and AI-driven analytics. These animal-free systems enable predictive modeling of disease and drug response in liver, brain, and barrier tissues, supporting FDA Modernization Act 2.0 and Next-Generation Risk Assessment (NGRA) initiatives. The company’s PhD-level team integrates tissue engineering, stem-cell biology, and data science to deliver validated, reproducible models that accelerate translational innovation for government, pharmaceutical, and academic partners.